Prevalence of coronary artery disease in patients with valvular heart disease. 1985

B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson

To evaluate the usefulness of preoperatie coronary angiography in patients undergoing preoperative investigation because of valvular heart disease, we performed coronary angiography in a consecutive series of 329 patients. The prevalence of significant coronary artery disease was 32%. Asymptomatic coronary artery disease was present in 13%. Angina pectoris proved to be a poor predictor of coronary artery disease in aortic valve disease. In mitral valve disease, however, the specificity was high. A cost-benefit calculation was carried out in order to assess what advantage routine coronary angiography might have. According to this, coronary angiography should be performed in all patients suffering from valvular heart disease with angina pectoris, whereas it can be omitted in younger patients without angina. A cut-off point of 60 years seems appropriate for aortic valve disease and 65 years for mitral valve disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D005260 Female Females
D006349 Heart Valve Diseases Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). Heart Valvular Disease,Valvular Heart Diseases,Disease, Heart Valvular,Heart Disease, Valvular,Heart Valve Disease,Heart Valvular Diseases,Valve Disease, Heart,Valvular Disease, Heart,Valvular Heart Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
January 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
March 2023, The heart surgery forum,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
September 2014, Journal of cardiothoracic surgery,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
January 1986, Zeitschrift fur Kardiologie,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
January 1989, Cor et vasa,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
September 1997, European heart journal,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
December 2012, Coronary artery disease,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
December 1980, British heart journal,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
January 1986, Zeitschrift fur Kardiologie,
B O Olofsson, and P Bjerle, and T Aberg, and G Osterman, and K A Jacobsson
August 1981, British heart journal,
Copied contents to your clipboard!